DXR Daxor Corporation
$8.89▼ -3.47%
Healthcare
Other
Volume 8.2K
Avg Volume (10D) 13.2K
Key Metrics & Fundamentals
Market Cap
$51.90M
P/E Ratio
8.1
Div Yield
0.00%
52W Range
8.56 - 14.76
% vs 50 MA
-15.35%
% vs 200 MA
-17.62%
RSI-14
25.9
MACD Histogram
-0.1400
Beta (1Y vs SPY)
0.11
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
GlobeNewswire · Oct 15, 2026 8:00 AM ET
Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026
GlobeNewswire · Oct 14, 2026 8:00 AM ET
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
GlobeNewswire · Oct 13, 2026 8:00 AM ET
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
GlobeNewswire · Oct 1, 2026 8:00 AM ET
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
GlobeNewswire · Sep 8, 2026 5:40 PM ET
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
GlobeNewswire · Sep 1, 2026 8:00 AM ET
Daxor Launches Blood Testing Lab in Eastern Kansis
MT Newswires · Jul 30, 2026 5:27 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.